Company profile
Talaris Therapeutics, Inc. Insider Trading
TRMLEvery SEC Form 4 insider trading filing for Talaris Therapeutics, Inc. (TRML) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001827506
- Filings
- 77
- Insiders
- 20
- Last filing
- 2025-10-28
Activity summary
No insider transactions in the last 30 days. The most recent was on October 28, 2025, when Sapna Srivastava sold 518 shares. 77 filings from 20 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q1 23 to Q4 25. Talaris Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $3.3M.
No insider activity recorded for TRML in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 28, 2025 | Sapna Srivastava | TRML | U | 518 | — | — |
| Oct 28, 2025 | Parvinder Thiara | TRML | Disposition | 10,000 | — | — |
| Oct 28, 2025 | Ryan F. Robinson | TRML | Disposition | 58,000 | — | — |
| Oct 28, 2025 | Sapna Srivastava | TRML | Disposition | 16,800 | — | — |
| Oct 28, 2025 | Clay B Siegall | TRML | Disposition | 16,800 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TRML" \
-H "X-Api-Key: $KEY"